Aratana Therapeutics, Inc.
(NASDAQ : PETX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
0.72%190.252.8%$351.98m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
1.18%21.522.1%$261.22m
ZTSZoetis, Inc. Class A
-0.05%91.791.9%$200.77m
MYLMylan N.V.
0.19%32.483.2%$167.91m
TXMDTherapeuticsMD, Inc.
-1.80%5.4625.8%$15.28m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
1.99%34.832.0%$9.52m
ABEOAbeona Therapeutics, Inc.
-0.72%9.647.9%$6.72m
TAROTaro Pharmaceutical Industries Ltd.
0.20%94.576.3%$4.42m
KINKindred Biosciences, Inc.
-2.60%12.730.3%$3.20m
JAGXJaguar Animal Health, Inc.
0.00%0.549.8%$2.62m
PETXAratana Therapeutics, Inc.
-1.11%5.348.7%$1.48m
LFVNLifeVantage Corporation
-1.06%10.293.3%$1.41m
CPHIChina Pharma Holdings, Inc.
1.33%0.460.1%$0.63m

Company Profile

Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.